Drreddys Laboratories reported $163.27B in Current Assets for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Ani Pharmaceuticals ANIP:US $ 301.4M 20.38M
Aurora Cannabis Inc ACB:CN 696.63M 92.19M
Bayer BAYN:GR 38.25B 5.67B
Canopy Growth Corp WEED:CN C$ 1.74B 250.75M
Catalent CTLT:US $ 3025M 51M
Corcept Therapeutics CORT:US $ 388.22M 121.76M
Endo International Ordinary Shares ENDP:US $ 2492.79M 221.79M
GlaxoSmithKline GSK:LN 28.99B 10.31B
Hikma Pharmaceutical HIK:LN 2.09B 139M
Horizon Pharma HZNP:US $ 2947.73M 147.96M
JAZZ PHA JAZZ:US $ 2500.86M 110.48M
Lannett LCI:US $ 318.7M 15.91M
Lonza Group LONN:SW 5.96B 925M
Novartis NOVN:VX 37.24B 8.48B
Pacira Pharmaceuticals PCRX:US $ 667.02M 199.03M
Phibro Animal Health PAHC:US $ 546.48M 37.87M
Prestige Brands PBH:US $ 293.27M 18M
Richter Gedeon RICHT:HB 429.04B 16.42B
Supernus Pharmaceuticals SUPN:US $ 568.52M 33.07M
Teva Pharmaceutical TEVA:IT 12.45B 122M